Lymphocytic Leukemia

What is lymphocytic leukemia?

Lymphocytic leukemia is a cancer of the blood and bone marrow that starts in lymphocytes, a type of white blood cell that normally helps the body fight infection. Bone marrow is the soft tissue inside the bones where blood cells are made. In lymphocytic leukemia, the marrow produces large numbers of abnormal lymphocytes that do not work properly and that crowd out healthy blood cells. The term is often used interchangeably with lymphoid leukemia or lymphoblastic leukemia.

When people ask what is lymphocytic leukemia, it helps to know there are two main forms, and they behave very differently:

• Acute lymphocytic leukemia (ALL), also called acute lymphoblastic leukemia, develops quickly. Immature lymphocytes, called lymphoblasts, multiply rapidly and usually cause symptoms within weeks. ALL is the most common cancer in children, although it can also affect adults.
• Chronic lymphocytic leukemia (CLL) develops slowly, sometimes over many years. The abnormal cells are more mature and may cause no symptoms for a long time. CLL mainly affects older adults and is rare in children.

Both forms are treated by specialists in hematology (the study of blood disorders) and oncology (the treatment of cancer). In many hospitals, including within Acibadem, care is coordinated through the Medical Oncology Department together with hematology teams.

Lymphocytic leukemia symptoms

Lymphocytic leukemia symptoms are largely caused by two problems: too few healthy blood cells, and abnormal lymphocytes building up in the marrow, lymph nodes, spleen, and liver. Common symptoms include:

• Persistent tiredness or weakness
• Frequent or unusually severe infections
• Fever without an obvious cause
• Easy bruising, nosebleeds, or bleeding gums
• Small red or purple spots on the skin (petechiae)
• Pale skin and shortness of breath on exertion
• Swollen, usually painless lymph nodes in the neck, armpits, or groin
• A feeling of fullness or discomfort below the ribs from an enlarged spleen or liver
• Bone or joint pain
• Night sweats and unintended weight loss

In acute lymphocytic leukemia, symptoms tend to appear suddenly and worsen over days or weeks. Children may become unusually irritable, lose their appetite, or complain of aching legs. Because ALL can spread to the brain and spinal cord, some people develop headaches, vomiting, or blurred vision. Occasionally the disease involves the testicles, causing painless swelling.

In chronic lymphocytic leukemia, many people have no symptoms at all when the condition is found, and it is often discovered on a routine blood test done for another reason. When symptoms do appear, they usually develop gradually. Enlarged lymph nodes, fatigue, and repeated infections are among the more common early signs. In later stages, anemia (a shortage of red blood cells) and low platelets (the cells that help blood clot) may cause paleness, breathlessness, and bleeding.

These symptoms overlap with many less serious conditions, so having one or more of them does not mean a person has leukemia. Only medical testing can determine the cause.

Causes and risk factors

Doctors do not fully understand lymphocytic leukemia causes. What is known is that the disease begins when a developing lymphocyte acquires changes, called mutations, in its DNA. DNA is the genetic material that instructs a cell how to grow and when to die. These mutations allow the cell to keep dividing and to survive when it should not. Over time, the abnormal cells accumulate and interfere with normal blood production.

In most people, these DNA changes happen during life and are not inherited from a parent. Researchers have identified several factors that appear to raise the risk, though most people with these factors never develop leukemia, and many people with leukemia have none of them.

• Age: ALL is most common in young children and again in older adults; CLL is mainly a disease of people over 60.
• Sex: both forms are somewhat more common in males.
• Family history: having a close relative with CLL or another blood cancer raises the risk of CLL. A strong inherited pattern is less clear for ALL.
• Genetic conditions: certain inherited disorders, such as Down syndrome, are linked to a higher risk of ALL.
• Previous cancer treatment: some chemotherapy drugs and radiation therapy can increase the chance of developing leukemia years later.
• Radiation exposure: high doses of ionizing radiation are an established risk factor.
• Chemical exposure: long-term exposure to certain chemicals, such as benzene and some agricultural chemicals, has been associated with an increased risk.

Everyday factors such as diet, stress, or minor infections are not considered causes of lymphocytic leukemia. The disease is not contagious and cannot be passed from one person to another.

Lymphocytic leukemia diagnosis

Lymphocytic leukemia diagnosis begins with a medical history and a physical examination. The doctor checks for enlarged lymph nodes, an enlarged spleen or liver, pale skin, bruising, and signs of infection. The diagnosis is then confirmed with laboratory tests.

• Complete blood count (CBC): this basic blood test measures red cells, white cells, and platelets. A very high number of lymphocytes, or low numbers of red cells and platelets, may point toward leukemia.
• Peripheral blood smear: a drop of blood is examined under a microscope to look at the size, shape, and maturity of the white cells. Immature lymphoblasts suggest ALL; large numbers of small, mature-looking lymphocytes suggest CLL.
• Flow cytometry (immunophenotyping): this test uses antibodies and lasers to identify specific proteins on the surface of the cells. It shows whether the abnormal cells come from B-lymphocytes or T-lymphocytes and is often enough on its own to confirm CLL from a blood sample.
• Bone marrow aspiration and biopsy: a thin needle is used, usually at the back of the hip bone, to draw out a small amount of liquid marrow and a tiny core of bone. Local anesthetic is used. This test is generally required to confirm ALL and to assess how much of the marrow is involved.
• Cytogenetic and molecular tests: the chromosomes and genes of the leukemia cells are analyzed. Certain changes, such as the Philadelphia chromosome in some ALL cases or deletions on chromosome 17 in CLL, influence which treatments are likely to work and how closely the disease needs to be monitored.
• Lumbar puncture (spinal tap): in ALL, a small sample of the fluid around the spinal cord is taken to check whether leukemia cells have reached the nervous system.
• Imaging: a chest X-ray, ultrasound, or CT scan may be used to look at lymph nodes, the spleen, and the liver, or to check for a mass in the chest that sometimes occurs with T-cell ALL. Imaging cannot diagnose leukemia on its own.

For CLL, doctors also assign a stage based on the number of enlarged lymph node areas, the size of the spleen and liver, and the blood counts. For ALL, there is no traditional staging; instead the disease is described by cell type, genetic features, and whether it has spread to the nervous system. These details, along with a person’s age and general health, guide the treatment plan.

Lymphocytic leukemia treatment options

Lymphocytic leukemia treatment options depend mainly on whether the disease is acute or chronic, the genetic features of the leukemia cells, the person’s age and overall health, and, for CLL, whether the disease is causing problems. Treatment is planned by a team that usually includes a hematologist, a medical oncologist, specialist nurses, and, when needed, a transplant team.

Observation (watch and wait). Many people with early-stage CLL who have no symptoms do not need immediate treatment. Studies have not shown a benefit from treating this group early, so doctors often recommend regular check-ups and blood tests instead. Treatment is started if symptoms develop, blood counts fall, or lymph nodes or the spleen enlarge significantly. Observation is not used for ALL, which requires prompt treatment.

Chemotherapy. Chemotherapy uses drugs that kill rapidly dividing cells. It remains the foundation of treatment for ALL and is given in phases: induction (to bring the disease into remission, meaning no detectable leukemia in the blood or marrow), consolidation (to eliminate remaining hidden cells), and maintenance (lower-dose treatment continued for a longer period). Treatment for ALL also includes medication delivered into the spinal fluid to prevent or treat involvement of the nervous system. Chemotherapy is used less often for CLL today, but it still has a role for some patients, frequently combined with other drugs.

Targeted therapy. These medicines act on specific molecules that leukemia cells depend on. In CLL, oral drugs that block signaling proteins inside the cell (such as BTK inhibitors and BCL-2 inhibitors) have become standard options and are often preferred over chemotherapy. In ALL with the Philadelphia chromosome, drugs called tyrosine kinase inhibitors are added to chemotherapy.

Immunotherapy. Immunotherapy helps the immune system recognize and destroy cancer cells. Monoclonal antibodies, which are laboratory-made proteins that attach to markers on leukemia cells, are used in both CLL and ALL. Newer approaches for ALL include antibodies that link leukemia cells to the patient’s own immune cells, and CAR T-cell therapy, in which a patient’s T-cells are collected, modified in a laboratory to attack the leukemia, and returned by infusion. CAR T-cell therapy is generally reserved for disease that has returned or has not responded to other treatments.

Radiation therapy. High-energy beams are sometimes used to treat leukemia that has spread to the brain, to shrink a large mass in the chest, or to relieve pain from an enlarged spleen or lymph nodes. It is not a main treatment for either form.

Stem cell transplant. Also called a bone marrow transplant, this procedure replaces the diseased marrow with healthy blood-forming stem cells, usually from a matched donor. It is preceded by high-dose chemotherapy, sometimes with radiation. Transplant may be considered for adults with high-risk ALL, for ALL that has relapsed, and occasionally for younger people with aggressive CLL. It carries significant risks, so the decision is made carefully.

Supportive care. Alongside anticancer treatment, patients often need transfusions of red cells or platelets, antibiotics or antiviral medicines to prevent and treat infections, growth factors to help blood counts recover, and medications to manage nausea and pain. Vaccinations, dental care, and nutritional support are also part of the plan.

Surgery and rehabilitation. Surgery is rarely used because leukemia is spread throughout the blood and marrow rather than confined to one place. Removal of the spleen is occasionally considered in CLL when it is very enlarged and causing severe low blood counts that do not respond to other measures. Rehabilitation, including physical therapy and psychological support, can help people regain strength after intensive treatment.

Clinical trials are an important part of leukemia care, and your doctor may discuss whether a trial is appropriate for your situation.

Living with lymphocytic leukemia and outlook

The outlook for lymphocytic leukemia varies widely and depends on the type, the genetic features of the leukemia cells, how the disease responds to initial treatment, and the person’s age and general health. Doctors use these factors to estimate risk, but no one can predict the course of the disease for an individual with certainty.

In children, ALL has become one of the more successfully treated cancers, and many children who complete treatment remain free of disease long term. Outcomes in adults with ALL are generally less favorable than in children, although newer targeted and immune-based therapies are changing this picture. Treatment for ALL is intensive and typically lasts two to three years, including the maintenance phase, and it can have lasting effects on growth, fertility, heart health, and learning that need long-term follow-up.

CLL is usually considered a long-term condition rather than one that is cured. Many people live for years, sometimes decades, and some never require treatment. Others have a more aggressive form that needs early and repeated therapy. Because the disease weakens the immune system, people with CLL are more prone to infections and to certain other cancers, so regular monitoring and preventive care are important.

Day-to-day life with lymphocytic leukemia often involves managing fatigue, attending frequent appointments, and coping with uncertainty. Practical steps that many patients find helpful include keeping up with recommended vaccinations, practicing careful hand hygiene, reporting fevers promptly, eating a balanced diet, staying as physically active as energy allows, and seeking emotional support from counselors, support groups, or trusted people. Your care team can help you understand which precautions matter most at each stage of treatment.

Frequently asked questions

What is lymphocytic leukemia in simple terms?

Lymphocytic leukemia is a cancer in which the bone marrow makes too many abnormal lymphocytes, a type of white blood cell. These cells do not fight infection properly and crowd out healthy red cells, platelets, and normal white cells. It comes in an acute form that progresses quickly and a chronic form that usually progresses slowly.

What are the first lymphocytic leukemia symptoms people notice?

Early symptoms often include tiredness, frequent infections, unexplained fever, easy bruising or bleeding, and swollen lymph nodes. In chronic lymphocytic leukemia there may be no symptoms at all at first, and the condition is frequently detected on a routine blood test. In the acute form, symptoms usually appear over a few weeks and worsen steadily.

What are the main lymphocytic leukemia causes?

The direct cause is DNA damage in a developing lymphocyte that allows it to multiply out of control. Why this damage occurs is usually unknown. Recognized risk factors include older age for CLL, certain genetic conditions such as Down syndrome for ALL, previous chemotherapy or radiation, high radiation exposure, some chemical exposures, and a family history of CLL. Lifestyle factors have not been clearly linked.

How is lymphocytic leukemia diagnosis confirmed?

Diagnosis relies on blood tests, including a complete blood count and a microscopic review of the blood cells, followed by flow cytometry to identify the type of lymphocyte involved. A bone marrow biopsy is usually needed for ALL. Genetic tests on the leukemia cells help classify the disease and guide treatment. Imaging may be used to assess lymph nodes and organs but does not confirm the diagnosis on its own.

What are the lymphocytic leukemia treatment options for the chronic form?

Early-stage CLL without symptoms is often managed by observation with regular check-ups. When treatment is needed, options include oral targeted drugs, monoclonal antibodies, and in some cases chemotherapy, often in combination. Stem cell transplant is considered only in selected younger patients with high-risk disease. The choice depends on genetic features of the leukemia, age, and other health conditions.

Is lymphocytic leukemia curable?

Acute lymphocytic leukemia can often be cured, particularly in children, though outcomes vary with age and genetic risk factors. Chronic lymphocytic leukemia is generally regarded as controllable rather than curable with current standard treatments, but many people live for a long time with the disease, and some never need therapy. Your doctor can explain what the specific features of your disease mean for your situation.

Is lymphocytic leukemia hereditary?

Most cases are not inherited. However, having a parent, sibling, or child with CLL does increase the risk of developing CLL compared with the general population. For ALL, an inherited link is much weaker, although some rare genetic syndromes raise the risk. Genetic counseling may be offered when a strong family pattern is present.

When to see a doctor

Anyone with persistent, unexplained symptoms such as ongoing fatigue, repeated infections, swollen lymph nodes that do not go away, unexplained bruising, night sweats, or unintended weight loss should be evaluated by a doctor. These symptoms have many possible causes, and a simple blood test is often the first step in finding out what is happening.

People who have already been diagnosed with lymphocytic leukemia, and especially those receiving treatment, should seek urgent medical attention for the following red-flag signs:

• Fever of 38 °C (100.4 °F) or higher, chills, or shaking, particularly during chemotherapy, when infection can become serious very quickly
• Bleeding that will not stop, blood in the urine or stool, vomiting blood, or a sudden spread of small red or purple spots on the skin
• Severe shortness of breath, chest pain, or a racing heartbeat
• Severe headache, confusion, drowsiness, seizures, vision changes, or new weakness or numbness
• Severe abdominal pain or a rapidly enlarging, painful belly, which can signal a problem with the spleen
• Signs of a serious allergic or infusion reaction during or shortly after treatment, such as swelling of the face or throat, hives, or difficulty breathing
• Inability to keep down fluids, very little urine, or dizziness on standing, which may indicate dehydration

These situations can be life-threatening and require emergency care. If you are unsure whether a symptom is urgent, it is safer to have it checked promptly than to wait.